+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Cardiopulmonary Oxygenator Market Forecast to 2028 -Regional Analysis

  • PDF Icon

    Report

  • 122 Pages
  • June 2023
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5887958
The Asia Pacific cardiopulmonary oxygenator market was valued at US$ 164.51 million in 2022 and is expected to reach US$ 214.77 million by 2028. It is estimated to register a CAGR of 4.5% from 2022 to 2028.

Increasing Surgical Procedures with Surging in Aging Population is Fueling Asia Pacific Cardiopulmonary Oxygenator Market

Surgical procedures are necessary for managing health conditions such as cardiovascular diseases and lung disorders. In some medical cases, no alternative works without surgery. Per an article published in the National Center for Biotechnology Information (NCBI) in 2020, ~310 million major surgical operations are carried out each year worldwide, of which 50-60 million are performed in the US. The high demand for cardiovascular surgeries can be attributed to the increase in the incidence of cardiovascular diseases in the aging population. Further, lung transplantation may be the only helpful treatment option for patients experiencing serious lung damage and non-resolving COVID-19-associated respiratory failure. Thus, with the growing number of cardiovascular and lung transplant surgeries, the demand for cardiopulmonary oxygenators is also on the rise in the region.

According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Cardiovascular diseases continue to be the leading cause of death among adults over the age of 65. Aging can cause changes in the heart and blood vessels, increasing the risk of developing these diseases. Therefore, the prevalence of cardiovascular diseases among geriatric populations is contributing to the growth of the cardiopulmonary oxygenators market.

Asia Pacific Cardiopulmonary Oxygenator Market Overview

The Asia Pacific cardiopulmonary oxygenator market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest market share in 2021, and India is expected to register a significant CAGR in the market.

Despite progress in the availability of effective and safe prevention strategies worldwide, cardiovascular disease (CVD) remains the leading cause of death and premature death globally. According to the Global Burden of Diseases Study, in 2019, out of the total 18.6 million CVD deaths worldwide, 58% of them occurred in Asia. As the continent with the largest population and greatest diversity of cultures, ethnicities, socioeconomic status, and health care systems, Asia faces many challenges in CVD prevention and treatment. The growth of the market is mainly attributed to the increasing prevalence of atrial fibrillation (AF) in China, the increasing burden of various other heart diseases, and the rising geriatric population across the region are all expected to support market growth. As per the prediction done by World Heart Federation, cardiovascular events like ischemic heart disease and stroke are expected to rise by 50% among the Chinese population between 2010 and 2030. The Indian Heart Association stated that 50% of heart attacks occur under the age of 50, while 25% of the heart attacks occur under 25 years of age. Both the male and female populations in the country equally exhibit the risk of developing heart disease. Moreover, stroke is one of the atrial fibrillation's frequent and devastating complications. About one-third of the patients with atrial fibrillation are asymptomatic and atrial fibrillation may go undetected in the patients until symptoms develop. As the oxygenator supplies oxygen, by removing carbon dioxide, to the artery during heart surgeries therefore the heart is relieved from performing pumping duties. Thus growing prevalence of cardiovascular disease in the region is fueling the demand for cardiopulmonary oxygenator market.

As per the Frontier Media Public Health report published in June 2022, the most recent Chinese national survey of COPD showed that China accounted for almost 25% of all COPD cases globally. As compared with the survey results 10 years ago, the prevalence of COPD has increased by 67% in the aged 40 years or older group and has reached epidemic proportions. Moreover, asthma is a major public health challenge in the country, and it affects millions of people, according to the National Library of Medicine, the prevalence of asthma was 4.2% which represented 45.7 million people in the country in 2019, this has further increased the demand for respiratory inhalers. Moreover, the beginning of the COVID-19 pandemic from Wuhan city in China had led to the development of severe acute respiratory syndrome among the large population which in turn created the demand for the cardiopulmonary oxygenator market. Moreover, during the COVID-19 pandemic India is the second most affected country in the region which the second highest number of cases with different waves of COVID which has raised the growth of cardiopulmonary oxygenator market.

Therefore, growing prevalence of cardiovascular as well as respiratory diseases in the population of Asia Pacific is fueling the demand for cardiopulmonary oxygenator.

Asia Pacific Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Cardiopulmonary Oxygenator Market Segmentation

The Asia Pacific cardiopulmonary oxygenator market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.

Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.

Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.

Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.

Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.

Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market share in 2022.

Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Eurosets SRL; Nipro Medical Corp; Microport Scientific Corp; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the cardiopulmonary oxygenator market in the region.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Cardiopulmonary Oxygenator Market - by Product
1.3.2 Asia Pacific Cardiopulmonary Oxygenator Market - by Application
1.3.3 Asia Pacific Cardiopulmonary Oxygenator Market - by Type
1.3.4 Asia Pacific Cardiopulmonary Oxygenator Market - by Age Group
1.3.5 Asia Pacific Cardiopulmonary Oxygenator Market - by End Use
1.3.6 Asia Pacific Cardiopulmonary Oxygenator Market - by Country
2. Asia Pacific Cardiopulmonary Oxygenator Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Cardiopulmonary Oxygenator Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. Asia Pacific Cardiopulmonary Oxygenators Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Incidence of Cardiopulmonary Diseases
5.1.2 Increasing Surgical Procedures with Surging in Aging Population
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increasing Usage of Cardiopulmonary Oxygenators in Pediatric and Neonatal Patients
5.4 Future Trends
5.4.1 Use of Portable Extracorporeal Membrane Oxygenation in Lung Transplant Procedures
5.5 Impact Analysis
6. Cardiopulmonary Oxygenators Market - Asia Pacific Analysis
6.1 Asia Pacific Cardiopulmonary Oxygenators Market Revenue Forecast and Analysis
7. Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Product
7.1 Overview
7.2 Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Membrane Oxygenator
7.3.1 Overview
7.3.2 Membrane Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Bubble Oxygenator
7.4.1 Overview
7.4.2 Bubble Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Application
8.1 Overview
8.2 Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
8.3 Cardiac
8.3.1 Overview
8.3.2 Cardiac: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.3 Acute myocardial infarction
8.3.4 Overview
8.3.5 Acute myocardial infarction: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.6 Myocarditis
8.3.7 Overview
8.3.8 Myocarditis: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.9 Post-transplant complication
8.3.10 Overview
8.3.11 Post-transplant complication: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.12 Decompensated Cardiomyopathy
8.3.13 Overview
8.3.14 Decompensated Cardiomyopathy: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.15 Others
8.3.16 Overview
8.3.17 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Respiratory
8.4.1 Overview
8.4.2 Respiratory: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.3 Respiratory Failure
8.4.4 Overview
8.4.5 Respiratory Failure: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.6 Acute Respiratory Distress Syndrome
8.4.7 Overview
8.4.8 Acute Respiratory Distress Syndrome: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.9 Pulmonary Embolism
8.4.10 Overview
8.4.11 Pulmonary Embolism: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.12 Pneumonia
8.4.13 Overview
8.4.14 Pneumonia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.15 COVID-19
8.4.16 Overview
8.4.17 COVID-19: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Type
9.1 Overview
9.2 Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
9.3 Reusable Oxygenator
9.3.1 Overview
9.3.2 Reusable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Disposable Oxygenator
9.4.1 Overview
9.4.2 Disposable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Age Group
10.1 Overview
10.2 Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
10.3 Adults
10.3.1 Overview
10.3.2 Adults: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Pediatric
10.4.1 Overview
10.4.2 Pediatric: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Neonates
10.5.1 Overview
10.5.2 Neonates: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
11. Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by End Use
11.1 Overview
11.2 Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
11.3 Hospitals and Clinics
11.3.1 Overview
11.3.2 Hospitals and Clinics: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
11.4 Ambulatory Surgical Centers
11.4.1 Overview
11.4.2 Ambulatory Surgical Centers: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12. Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Country Analysis
12.1 Asia Pacific: Cardiopulmonary Oxygenators Market
12.1.1 Overview
12.1.2 Asia Pacific: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
12.1.2.1 China: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 China: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.1.2 China: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.1.3 China: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.1.3.1 China: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.1.3.2 China: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.1.4 China: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.1.5 China: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.1.6 China: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
12.1.2.2 Japan: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 Overview
12.1.2.2.2 Japan: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.2.3 Japan: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.2.4 Japan: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.2.4.1 Japan: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.2.4.2 Japan: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.2.5 Japan: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.2.6 Japan: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.2.7 Japan: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
12.1.2.3 India: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 Overview
12.1.2.3.2 India: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.3.3 India: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.3.4 India: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.3.4.1 India: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.3.4.2 India: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.3.5 India: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.3.6 India: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.3.7 India: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
12.1.2.4 Australia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 Overview
12.1.2.4.2 Australia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.4.3 Australia: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.4.4 Australia: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.4.4.1 Australia: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.4.4.2 Australia: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.4.5 Australia: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.4.6 Australia: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.4.7 Australia: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
12.1.2.5 South Korea: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.5.1 Overview
12.1.2.5.2 South Korea: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.5.3 South Korea: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.5.4 South Korea: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.5.4.1 South Korea: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.5.4.2 South Korea: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.5.5 South Korea: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.5.6 South Korea: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.5.7 South Korea: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
12.1.2.6 Rest of Asia Pacific: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.6.1 Overview
12.1.2.6.2 Rest of Asia Pacific: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
12.1.2.6.3 Rest of Asia Pacific: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.6.4 Rest of Asia Pacific: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.6.4.1 Rest of Asia Pacific: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.6.4.2 Rest of Asia Pacific: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.6.5 Rest of Asia Pacific: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.6.6 Rest of Asia Pacific: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.6.7 Rest of Asia Pacific: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
13. Asia Pacific Cardiopulmonary Oxygenators Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies in Cardiopulmonary Oxygenator Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 LivaNova Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Medtronic Plc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Terumo Corp
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Eurosets SRL
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Nipro Medical Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 MicroPort Scientific Corp
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Chalice Medical Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Fresenius Medical Care AG & Co KGaA
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Publisher
15.2 Glossary of Terms
List of Tables
Table 1. China Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 2. China Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 3. China Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 4. China Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
Table 5. China Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 6. China Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 7. China Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 8. Japan Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 9. Japan Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 10. Japan Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 11. Japan Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
Table 12. Japan Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 13. Japan Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 14. Japan Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 15. India Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 16. India Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 17. India Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 18. India Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
Table 19. India Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 20. India Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 21. India Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 22. Australia Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 23. Australia Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 24. Australia Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 25. Australia Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
Table 26. Australia Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 27. Australia Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 28. Australia Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 29. South Korea Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 30. South Korea Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 31. South Korea Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 32. South Korea Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
Table 33. South Korea Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 34. South Korea Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 35. South Korea Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 37. Rest of Asia Pacific Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 38. Rest of Asia Pacific Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 39. Rest of Asia Pacific Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
Table 40. Rest of Asia Pacific Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 41. Rest of Asia Pacific Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 42. Rest of Asia Pacific Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 43. Recent Organic Growth Strategies in Asia Pacific Cardiopulmonary Oxygenator Market
Table 44. Recent Inorganic Growth Strategies in The Asia Pacific Cardiopulmonary Oxygenator Market
Table 45. Glossary of Terms
List of Figure
Figure 1. Asia Pacific Cardiopulmonary Oxygenator Market Segmentation
Figure 2. Asia Pacific Cardiopulmonary Oxygenator Market, by region
Figure 3. Asia Pacific Cardiopulmonary Oxygenator Market Overview
Figure 4. Membrane Oxygenator Segment Held Largest Share of Product Segment in Cardiopulmonary Oxygenator Market
Figure 5. China Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Asia Pacific Experts’ Opinion
Figure 8. Asia Pacific Cardiopulmonary Oxygenators Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Cardiopulmonary Oxygenators Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. Asia Pacific Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
Figure 11. Membrane Oxygenator: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Bubble Oxygenator: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Asia Pacific Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
Figure 14. Cardiac: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Acute myocardial infarction: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Myocarditis: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Post-transplant Complication: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Decompensated Cardiomyopathy: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Respiratory: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Respiratory Failure: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Acute Respiratory Distress Syndrome: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Pulmonary Embolism: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pneumonia: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. COVID-19: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Asia Pacific Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
Figure 27. Reusable Oxygenator: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Disposable Oxygenator: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
Figure 30. Adults: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Pediatric: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Neonates: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Asia Pacific Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
Figure 34. Hospitals and Clinics: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Ambulatory Surgical Centers: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others: Asia Pacific Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Asia Pacific: Cardiopulmonary Oxygenators Market, by Key Country - Revenue (2021) (USD Million)
Figure 38. Asia Pacific: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
Figure 39. China: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
Figure 40. Japan: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. India: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. Australia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. South Korea: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. Rest of Asia Pacific: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Asia Pacific Growth Strategies in Cardiopulmonary Oxygenator Market

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • Terumo Corp
  • Eurosets SRL
  • Nipro Medical Corp
  • Microport Scientific Corp
  • Chalice Medical Ltd
  • Fresenius Medical Care AG & Co KGaA

Table Information